Compare KEN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KEN | INDV |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 4.1B |
| IPO Year | N/A | N/A |
| Metric | KEN | INDV |
|---|---|---|
| Price | $61.90 | $35.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 10.2K | ★ 2.2M |
| Earning Date | 12-03-2025 | 10-30-2025 |
| Dividend Yield | ★ 7.83% | N/A |
| EPS Growth | ★ 177.70 | N/A |
| EPS | ★ 8.96 | 0.98 |
| Revenue | $803,304,000.00 | ★ $1,180,000,000.00 |
| Revenue This Year | N/A | $1.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $6.69 | $36.24 |
| Revenue Growth | ★ 8.15 | N/A |
| 52 Week Low | $27.10 | $7.62 |
| 52 Week High | $62.88 | $38.00 |
| Indicator | KEN | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 70.66 |
| Support Level | $59.90 | $35.40 |
| Resistance Level | $62.68 | $38.00 |
| Average True Range (ATR) | 1.09 | 1.00 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 74.19 | 58.66 |
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.